YTENQ — Yield10 Bioscience Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.26m
- $0.06m
Brief: Yield10 Bioscience Announces Closing Of $3.7 Mln Public Offering
Brief: Yield10 Bioscience, Inc. Q2 net income USD -3.7 million
Yield10 Bioscience Inc reports results for the quarter ended in June - Earnings Summary
Yield10 Bioscience Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Yield10 Bioscience Announces Pricing Of $3.7 Million Public Offering
Yield10 Bioscience Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Yield10 Bioscience Inc Reports Positive Results In First Field Test Of Stacked Herbicide Tolerance Traits In Camelina
Brief: Yield10 Bioscience Files Request For Regulatory Status Review
Brief: Yield10 Bioscience Files For Common Stock Offering Size Not Disclosed
Tender Offer
Brief: Yield10 Bioscience Got Letter Of Non-compliance From Nasdaq
Yield10 Bioscience Inc reports results for the quarter ended in March - Earnings Summary
Brief: Yield10 Bioscience Announces First Quarter 2023 Financial Results
BP Capital Markets - Tender Offer
Yield10 Bioscience Inc expected to post a loss of 63 cents a share - Earnings Preview
Yield10 Bioscience Inc expected to post a loss of 63 cents a share - Earnings Preview
Brief: Yield10 Bioscience Inc Says On May 3, Co Terminated Equity Distribution Agreement Dated Jan 23 With Maxim Group Llc
Yorkshire B.S. - Tender Offer
Brief: Yield10 Bioscience And Marathon Petroleum Corp Sign LOI For Potential Investment And Offtake Agreement For Camelina Feedstock Oil For Renewable Fuels